FNDC5 and colorectal carcinoma: The CRC risk of participants with high irisin levels was lower by 77.0% compared with the risk for those with low serum irisin levels (OR = 0.23, 95% CI 0.08–0.66, P < 0.01) after adjustment for age and gender (Model 1).